Join Evelyn Kelly at Catalent’s webinar: Small Molecule Orphan Drugs: Status Quo, Challenges, and Perspectives
February 07, 2023. 11:00am EST/4.00pm IST
Orphan Drug Consulting’s Evelyn Kelly will be a guest speaker on Catalent’s webinar: Small Molecule Orphan Drugs: Status Quo, Challenges, and Perspectives on February 7, 2023, at 11.00 am EST/4.00 pm IST.
In this webinar, subject matter experts will review the principal elements that motivate pharmaceutical companies to develop and market orphan drugs. Experts will also explain how the industry is using strategic partnerships to assist and reduce the difficulties associated with developing and producing orphan drugs in order to construct a sustainable orphan drug business model.
Evelyn will be presenting alongside Cornell Stamoran, Ph.D., Vice President, Strategy and Government Affairs, Catalent, and Mark Mollan, Vice President, Operations, Catalent. Evelyn will guide you through the best practices in supply chain for orphan drugs, and touch on key points such as,
- Working with low-volume drugs from an operational perspective.
- Flexible approaches to accommodate commercial needs.
- Why outsourcing manufacturing makes sense for orphan drugs.
About Orphan Drug Consulting Ltd
Orphan Drug Consulting coordinates product launches into the US, EU, and other international markets providing strategic support in the areas of supply chain, quality assurance, vendor management, and entity management with its team of experienced industry professionals. From full-service solutions to solving specific immediate requirements, Orphan Drug Consulting is your partner of choice to manage market complexities ensuring your successful product launch to meet your patients’ needs.
For more information contact Info@orphandrugconsulting.com